We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Shire has taken out an injunction limiting how Roche can talk about its haemophilia drug, as the two companies fight for a share of this $11 billion market.